版本:
中国

BRIEF-Therapix Biosciences and Hannover Medical School enter into clinical trial agreement

May 8 Therapix Biosciences Ltd

* Therapix Biosciences and the Hannover Medical School enter into an investigator-initiated clinical trial agreement to assess the effect of txh-ts01 in patients with tourette syndrome

* Therapix Biosciences - entered into trial agreement with hannover medical school to conduct proof-of-concept phase ii clinical study with lead compound, thx-ts01

* Therapix Biosciences - trial agreement to conduct proof-of-concept phase ii clinical study with thx-ts01, for patients suffering from tourette syndrome Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐